Skip to content

A small sample, prospective, randomized controlled study on the effect of lentinan injection on postoperative cognitive dysfunction after general anesthesia in elderly patients

A small sample, prospective, randomized controlled study on the effect of lentinan injection on postoperative cognitive dysfunction after general anesthesia in elderly patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063662
Enrollment
Unknown
Registered
2022-09-14
Start date
2022-09-19
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative cognitive dysfunction

Interventions

lentinan group:intravenous infusion of lentinan

Sponsors

Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients aged 60-75 who underwent elective laparoscopic abdominal surgery; (2) The duration of surgery and general anesthesia is more than 2 hours, and the postoperative hospital stay is at least 5 days; (3) No serious visual or auditory impairment, able to read text for neuropsychological tests; (4) No history of allergy to lentinan or severe allergy to other food and drugs. (5) The patients participated voluntarily and signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) The score of the Simple Intelligence Scale Test (MMSE) [18] is lower than 23; (2) Have a history of dementia, mental illness or other central nervous system diseases; (3) Taking sedatives, antidepressants or hormones; (4) Those who have taken lentinan for the past three months; (5) Those who are addicted to alcohol or drugs; (6) The patient has been enrolled in this study before (applicable to the case where the patient underwent a second abdominal surgery during the study period); (7) Those who cannot conduct long-term follow-up or have poor compliance; (8) Anemia or thrombocytopenia, Hb180/100mmHg).

Design outcomes

Primary

MeasureTime frame
Cognitive function;

Secondary

MeasureTime frame
inflammatory factor;Security indices;

Countries

China

Contacts

Public ContactYujuan Li
liyuj@mail.sysu.edu.cn15918734156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026